跳至主要内容
临床试验/NCT01361048
NCT01361048已完成2 期

Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Percentage of Participants Cured of Vaginal Trichmonas

研究概览

简要总结

The investigators are trying a combination vaginal product of higher dose metronidazole combined with miconazole to see if it is effective in treating vaginal trichomonas.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • presence of trichomonas

排除标准

  • pregnant or nursing
  • known immunodeficiency
  • allergy to study drugs
  • concurrent yeast infection
  • history of seizures or peripheral neuropathy
  • unwillingness to abstain from alcohol during treatment period and for 48 hrs after concurrent lithium
  • anticoagulation therapy, and abuse
  • patient expected to have menses within 8 days of enrollment

研究组 & 干预措施

oral metronidazole

Active Comparator

control arm

干预措施: oral metronidazole (Drug)

neo penotran forte

Experimental

neo penotran forte vaginal suppository twice a day for 7 days

干预措施: neo penotran forte (Drug)

neo penotran forte once a day

Experimental

neo penotran forte vaginal suppository once a day for 7 days

干预措施: neo penotran forte once a day (Drug)

结局指标

主要结局

Percentage of Participants Cured of Vaginal Trichmonas

时间窗: day 12-15

percentage of participants achieving microbiological cure of trichomonas

次要结局

  • Tolerability of the Study Product as Measured by Participant Self-report(day 12-15 day 30-35)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jane Schwebke

Professor of Medicine

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验